Protagonist Therapeutics, Inc. (PTGX)
USD 45.51
(1.16%)
USD 45.51
(1.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 60 Million | 26.58 Million | 27.35 Million | 28.62 Million | 231 Thousand | 30.92 Million |
| Cost of Revenue | 3.31 Million | 1.03 Million | 2.77 Million | - | - | - |
| Gross Profit | 56.68 Million | 25.54 Million | 24.58 Million | 28.62 Million | 231 Thousand | 30.92 Million |
| Operating Expenses | 153.65 Million | 157.95 Million | 153.2 Million | 93.14 Million | 80.75 Million | 73.19 Million |
| Selling, General and Administrative Expenses | 33.49 Million | 31.73 Million | 27.19 Million | 18.63 Million | 15.74 Million | 13.69 Million |
| Research and Development Expenses | 120.16 Million | 126.21 Million | 126 Million | 74.5 Million | 65 Million | 59.49 Million |
| Other Expenses | - | -80 Thousand | -149 Thousand | -46 Thousand | -1000.00 | - |
| Cost and Expenses | 153.65 Million | 157.95 Million | 153.2 Million | 93.14 Million | 80.75 Million | 73.19 Million |
| Operating Income | -93.65 Million | -131.37 Million | -125.84 Million | -64.51 Million | -80.52 Million | -42.26 Million |
| Interest Expense | - | - | - | 598 Thousand | 169 Thousand | - |
| Income Tax Expense | - | -3.98 Million | -2.92 Million | 1.3 Million | -691 Thousand | -799 Thousand |
| Earnings before Tax | -78.95 Million | -127.39 Million | -125.55 Million | -64.84 Million | -77.87 Million | -39.72 Million |
| Net Income | -78.95 Million | -123.41 Million | -122.62 Million | -66.15 Million | -77.18 Million | -38.92 Million |
| Earnings Per Share Basic | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 |
| Earnings Per Share Diluted | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 |
| Weighted Average Shares Outstanding | 56.76 Million | 49.04 Million | 46.32 Million | 34.39 Million | 25.89 Million | 22.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.76 Million | 49.04 Million | 46.32 Million | 34.39 Million | 25.89 Million | 22.36 Million |
| Gross Margin | 0.94 | 0.96 | 0.90 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -1.51 | -4.94 | -4.59 | -2.22 | -336.40 | -1.37 |
| Profit Margin | -1.32 | -4.64 | -4.48 | -2.31 | -334.14 | -1.26 |
| EBITDA | -90.34 Million | -131.37 Million | -123.07 Million | -63.66 Million | -78.3 Million | -39.19 Million |
| Earnings Before Tax Margin | -1.56 | -4.94 | -4.60 | -2.25 | -348.58 | -1.37 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.16 Million | 254.95 Million | 60 Million | 60 Million | - | - |
| Cost of Revenue | 892 Thousand | 820 Thousand | 832 Thousand | 3.31 Million | 827 Thousand | 821 Thousand |
| Gross Profit | 3.27 Million | 254.13 Million | 59.16 Million | 56.68 Million | -827 Thousand | -821 Thousand |
| Operating Expenses | 42.06 Million | 47.82 Million | 36.95 Million | 153.65 Million | 38.32 Million | 42.35 Million |
| Selling, General and Administrative Expenses | 8.54 Million | 14.09 Million | 8.05 Million | - | 7.66 Million | 9.17 Million |
| Research and Development Expenses | 33.52 Million | 33.73 Million | 28.89 Million | - | 30.66 Million | 33.18 Million |
| Other Expenses | 97 Thousand | -19 Thousand | 44 Thousand | -201 Thousand | -31 Thousand | -19 Thousand |
| Cost and Expenses | 42.96 Million | 48.64 Million | 36.95 Million | 153.65 Million | 38.32 Million | 42.35 Million |
| Operating Income | -38.79 Million | 206.3 Million | 23.04 Million | -93.65 Million | -38.32 Million | -42.35 Million |
| Interest Expense | - | - | 2.29 Million | - | - | - |
| Income Tax Expense | -676 Thousand | 3.32 Million | -4.24 Million | -14.89 Million | -827 Thousand | -3.91 Million |
| Earnings before Tax | -31.29 Million | 210.66 Million | 27.33 Million | -78.95 Million | -34.1 Million | -38.46 Million |
| Net Income | -30.61 Million | 207.34 Million | 27.33 Million | -78.95 Million | -34.1 Million | -38.46 Million |
| Earnings Per Share Basic | -0.50 | 3.41 | 0.45 | - | -0.58 | -0.68 |
| Earnings Per Share Diluted | -0.50 | 3.26 | 0.44 | - | -0.58 | -0.68 |
| Weighted Average Shares Outstanding | 61.3 Million | 60.85 Million | 60.38 Million | 56.76 Million | 59.18 Million | 56.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.3 Million | 63.59 Million | 61.79 Million | 56.76 Million | 59.18 Million | 56.77 Million |
| Gross Margin | 0.79 | 1.00 | 0.99 | 0.94 | - | - |
| EBIT Margin | -9.10 | 0.81 | 0.40 | - | - | - |
| Profit Margin | -7.35 | 0.81 | 0.46 | -1.32 | - | - |
| EBITDA | -37.9 Million | 207.12 Million | 23.88 Million | - | -38.32 Million | -41.53 Million |
| Earnings Before Tax Margin | -9.31 | 0.81 | 0.38 | -1.56 | - | - |
IPB
2337
SJM
3913
STX
0VBE